Impact of Sentinel Node Status and Other Risk Factors on the Clinical Outcome of Head and Neck Melanoma Patients

Authors:
  • NANeil A. Accortt
    Neil A. Accortt
  • RERichard Essner
    Richard Essner
  • MRMerrick Ross
    Merrick Ross
  • JGJeffrey E. Gershenwald
    Jeffrey E. Gershenwald
  • BPBarbara Pockaj
    Barbara Pockaj
  • HHHarald J. Hoekstra
    Harald J. Hoekstra
  • CGCarlos Garberoglio
    Carlos Garberoglio
  • RWRichard L. White
    Richard L. White
  • DCDavid Chu
    David Chu
  • MBMerrill Biel
    Merrill Biel
  • KCKim Charney
    Kim Charney

Abstract
During the past 3 decades, the incidence of cutaneous melanoma, including those of the head and neck (H&N), have increased significantly.1,2 At the same time, the metastatic rate has decreased, probably because of earlier diagnosis and surgical treatment.3 Before selective sentinel lymphadenectomy was widely used,4 nodal status from elective lymph node dissection was the most important prognostic predictor of recurrence and death.5,6 In the sentinel lymph node (SLN) era, SLN status has been shown to be an important prognosticator for recurrence and death.7,8

This publication has 19 references indexed in Scilit: